On July 14, the stock price of the US-listed company Sonnet BioTherapeutics Holdings, Inc. (SONN) rose 273.11% before market opening, with a pre-market trading price of $19.29, an increase of $14.05 from the previous trading price.
BlockBeats previously reported that the US-listed company Sonnet will merge to form Hyperliquid Strategies and launch a treasury strategy, holding 12.6 million HYPE tokens and $300 million in cash.




